Avai Bio annual total assets
2019
2020
2021
2022
2023
2024
2025
2026
Avai Bio Total Assets Growth & History (AVAI)
Avai Bio's total assets was $572,696 for fiscal 2026.
View full Avai Bio company overviewAvai Bio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $572,696 | $347,951 | +154.82% |
| 2025 | 2025-03-31 | $224,745 | −$97,269 | −30.21% |
| 2024 | 2024-03-31 | $322,014 | $80,554 | +33.36% |
| 2023 | 2023-03-31 | $241,460 | −$213,204 | −46.89% |
| 2022 | 2022-03-31 | $454,664 | −$361,605 | −44.30% |
| 2021 | 2021-03-31 | $816,269 | $396,298 | +94.36% |
| 2020 | 2020-03-31 | $419,971 | $389,448 | +1275.92% |
| 2019 | 2019-03-31 | $30,523 | — | — |
Avai Bio quarterly total assets
As of Mar 31, 2018
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $791,750 | $646,444 | +444.88% |
| Q4 2026 | 2026-03-31 | $572,696 | $347,951 | +154.82% |
| Q3 2026 | 2025-12-31 | $172,912 | −$1,974 | −1.13% |
| Q2 2026 | 2025-09-30 | $231,372 | $50,339 | +27.81% |
| Q1 2026 | 2025-06-30 | $145,306 | −$99,588 | −40.67% |
| Q4 2025 | 2025-03-31 | $224,745 | −$97,269 | −30.21% |
| Q3 2025 | 2024-12-31 | $174,886 | −$116,360 | −39.95% |
| Q2 2025 | 2024-09-30 | $181,033 | −$84,028 | −31.70% |
| Q1 2025 | 2024-06-30 | $244,894 | −$29,525 | −10.76% |
| Q4 2024 | 2024-03-31 | $322,014 | $80,554 | +33.36% |
| Q3 2024 | 2023-12-31 | $291,246 | $6,356 | +2.23% |
| Q2 2024 | 2023-09-30 | $265,061 | −$73,585 | −21.73% |
| Q1 2024 | 2023-06-30 | $274,419 | −$114,413 | −29.42% |
| Q4 2023 | 2023-03-31 | $241,460 | −$213,204 | −46.89% |
| Q3 2023 | 2022-12-31 | $284,890 | −$142,201 | −33.30% |
| Q2 2023 | 2022-09-30 | $338,646 | −$359,140 | −51.47% |
| Q1 2023 | 2022-06-30 | $388,832 | −$483,149 | −55.41% |
| Q4 2022 | 2022-03-31 | $454,664 | −$361,605 | −44.30% |
| Q3 2022 | 2021-12-31 | $427,091 | −$207,141 | −32.66% |
| Q2 2022 | 2021-09-30 | $697,786 | −$118,483 | −14.52% |
| Q1 2022 | 2021-06-30 | $871,981 | $380,658 | +77.48% |
| Q4 2021 | 2021-03-31 | $816,269 | $396,298 | +94.36% |
| Q3 2021 | 2020-12-31 | $634,232 | $467,973 | +281.47% |
| Q2 2021 | 2020-09-30 | $816,269 | $715,840 | +712.78% |
| Q1 2021 | 2020-06-30 | $491,323 | $478,609 | +3764.43% |
| Q4 2020 | 2020-03-31 | $419,971 | $389,448 | +1275.92% |
| Q3 2020 | 2019-12-31 | $166,259 | $119,972 | +259.19% |
| Q2 2020 | 2019-09-30 | $100,429 | $55,881 | +125.44% |
| Q1 2020 | 2019-06-30 | $12,714 | $9,500.76 | +295.68% |
| Q4 2019 | 2019-03-31 | $30,523 | $22,212 | +267.26% |
| Q3 2019 | 2018-12-31 | $46,287 | — | — |
| Q2 2019 | 2018-09-30 | $44,548 | — | — |
| Q1 2019 | 2018-06-30 | $3,213.24 | — | — |
| As of Mar 31, 2018 | 2018-03-31 | $8,311 | — | — |
Avai Bio total assets trends
Over the last five fiscal years, Avai Bio's total assets decreased from $816,269 to $572,696, a change of −$243,573. The latest reported quarter, Q1 2027, shows $791,750.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Avai Bio source filings ↗